These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 21348188)

  • 21. [Cardiomyopathy caused by carnitine deficiency].
    Vikre-Jørgensen J
    Ugeskr Laeger; 1993 Oct; 155(42):3390-2. PubMed ID: 8259632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left ventricle volume affects the result of mitral valve surgery for idiopathic dilated cardiomyopathy to treat congestive heart failure.
    Horii T; Suma H; Isomura T; Nomura F; Hoshino J
    Ann Thorac Surg; 2006 Oct; 82(4):1349-54; discussion 1354-5. PubMed ID: 16996932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A reversible cause of dilated cardiomyopathy: hypocalcemia].
    Benzarouel D; Hasni K; Ashab H; El Hattaoui M
    Ann Cardiol Angeiol (Paris); 2014 Apr; 63(2):102-6. PubMed ID: 22673741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. L-carnitine in children with idiopathic dilated cardiomyopathy.
    Kothari SS; Sharma M
    Indian Heart J; 1998; 50(1):59-61. PubMed ID: 9583289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A rare cause of reversible dilated cardiomyopathy: hypocalcemia.
    Avsar A; Dogan A; Tavli T
    Echocardiography; 2004 Oct; 21(7):609-12. PubMed ID: 15488088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hypertrophic cardiomyopathy with dilatation of the left ventricle and congestive heart failure: comparison with postmyocarditis cardiomegaly and hypertensive heart failure].
    Kawanishi H; Yokota Y; Hayakawa M; Kaku K; Kumaki T; Matsumoto K; Fujitani K; Ito Y; Inoh T; Fukuzaki H
    J Cardiogr; 1983 Sep; 13(3):537-50. PubMed ID: 6235295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency.
    Stanley CA
    Adv Pediatr; 1987; 34():59-88. PubMed ID: 3318304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome factors of idiopathic dilated cardiomyopathy in children - a long-term follow-up review.
    Azevedo VM; Santos MA; Albanesi Filho FM; Castier MB; Tura BR; Amino JG
    Cardiol Young; 2007 Apr; 17(2):175-84. PubMed ID: 17244382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient with Eating Disorder, Carnitine Deficiency and Dilated Cardiomyopathy.
    Fotino AD; Sherma A
    J La State Med Soc; 2015; 167(4):162-4. PubMed ID: 27159507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical outcome after left ventricular surgical remodeling in patients with idiopathic dilated cardiomyopathy referred for heart transplantation: short-term results.
    Bocchi EA; Bellotti G; Vilella de Moraes A; Bacal F; Moreira LF; Esteves-Filho A; Fukushima JT; Guimarães G; Stolf N; Jatene A; Pileggi F
    Circulation; 1997 Nov; 96(9 Suppl):II-165-71; discussion II-171-2. PubMed ID: 9386093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors and predictors of in-hospital mortality of patients with heart failure with preserved left ventricular ejection fraction.
    Pérez de Isla L; Zamorano J; Hernández N; Contreras L; Rodrigo JL; Almería C; Aubele AL; Mataix L; Macaya C
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1011-5. PubMed ID: 18799963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Carnitine metabolism--changes in the end stage of dilated cardiomyopathy and ischemic heart muscle disease].
    Regitz V; Müller M; Schüler S; Yankah CA; Hetzer R; Shug AL; Fleck E
    Z Kardiol; 1987; 76 Suppl 5():1-8. PubMed ID: 3324528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Carnitine-deficient cardiomyopathy].
    Kádár K; Melegh B; Szendrei E; Herczegfalvi A
    Orv Hetil; 1994 Feb; 135(9):473-4. PubMed ID: 8139852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary carnitine deficiency dilated cardiomyopathy: 28 years follow-up.
    Agnetti A; Bitton L; Tchana B; Raymond A; Carano N
    Int J Cardiol; 2013 Jan; 162(2):e34-5. PubMed ID: 22658351
    [No Abstract]   [Full Text] [Related]  

  • 35. Left ventricular geometry, myocardial function and energetics of the dilated left ventricle. Influence of vasodilators and positive inotropic substances.
    Holubarsch C; Hasenfuss G; Thierfelder L; Just H
    Herz; 1991 Sep; 16 Spec No 1():298-303. PubMed ID: 1820296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical outcome and reversibility of systolic dysfunction in patients with dilated cardiomyopathy due to hypertension and chronic heart failure].
    Anguita Sánchez M; Rodríguez Esteban M; Ojeda Pineda S; Ruiz Ortiz M; Romo Peña E; Mesa Rubio D; Vallés Belsué F
    Rev Esp Cardiol; 2004 Sep; 57(9):834-41. PubMed ID: 15373989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Indications for ACE inhibitors in chronic heart failure].
    Erdmann E
    Z Kardiol; 1994; 83 Suppl 4():75-9. PubMed ID: 7856285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Partial left ventriculectomy: preoperative risk factors for perioperative mortality.
    Bestetti RB; Moreira-Neto F; Brasil JC; Bombonato R; Sgarbieri RN; Haddad J
    Int J Cardiol; 1998 Dec; 67(2):143-6. PubMed ID: 9891947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case of dilated cardiomyopathy due to nutritional vitamin D deficiency rickets.
    Olgun H; Ceviz N; Ozkan B
    Turk J Pediatr; 2003; 45(2):152-4. PubMed ID: 12921304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three-year survival of patients with heart failure caused by dilated cardiomyopathy and L-carnitine administration.
    Rizos I
    Am Heart J; 2000 Feb; 139(2 Pt 3):S120-3. PubMed ID: 10650325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.